SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Alseres Pharmaceuticals
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
975 18 0 ALSE
Emcee:  SI (no user) Type:  Unmoderated
Introduction Market Data Compact
Anybody,
Although I don't know much on a fundamental basis here, technically something is going on. Closed above major resistance of $1.50 on over 6 million shares today. Volume is ever-increasing as price slowly moves higher, but 35 million shares outstanding prevents the huge burst. They have something in phase 3 trials, perhaps this is generating the interest????

JAG
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
975Here is an excerpt from the latest 10Q: As of September 30, 2013, we had experiJorgen Jensen-11/15/2013
974NEWS. License agreement for Altropane. finance.yahoo.comJorgen Jensen-7/31/2012
973Alseres Pharmaceuticals Completes Enrollment in First Stage of the Altropane(R) Jorgen Jensen-2/3/2009
972I know I'm just posting to myself. Coverage was initiated today by Vista ParJorgen Jensen-5/20/2008
971Alseres nears "miracle" - or a brick wall boston.comJorgen Jensen-1/27/2008
970Alseres Pharmaceuticals Concludes Enrollment in the Cethrin(R) Phase I/IIa CliniJorgen Jensen-1/7/2008
969BLSI changed it's name and stock symbol to Alseres ALSE in June, but I don&#Jorgen Jensen-1/2/2008
968Hope, Hype or real potential???? 11:58AM Boston Life Sciences announces extensiIan@SI-4/16/2007
967Other License Information The BioAxone license agreement provides for an up-froJorgen Jensen-1/4/2007
966HOPKINTON, Mass., Jan. 4 /PRNewswire-FirstCall/ -- Boston Life Sciences, Inc. (NJorgen Jensen-1/4/2007
965>>HOPKINTON, Mass., Sept. 25 /PRNewswire-FirstCall/ -- Boston Life Sciencetuck-9/25/2006
964Yep. Been holding since 2001.Jorgen Jensen-7/19/2006
963Anyone still interested in BLSI?SR/WA-7/18/2006
962Boston Life Sciences Ends ALTROPANE(R) POET-1 Phase III Trial Early to Evaluate Jorgen Jensen-3/20/2006
961And giving a lot back after hours. Seems to have finished at $2.75. One of my etuck-8/15/2005
960Finally some life in this old dog. Up 82% in the last hour of trading. BOSTON--Jorgen Jensen-8/15/2005
959About time: >>BOSTON--(BUSINESS WIRE)--July 26, 2004-- Boston Life Scienctuck-7/26/2004
958Trial now underway, while convert holders drop suit in turn for a board seat . tuck-6/16/2004
957I bought back in. Looks to be on the right track, Also take a gander at PPHM, anTadsamillionaire-4/1/2004
956We should know more tomorrow. Marc Lanser will be conducting a conference call aJorgen Jensen-4/1/2004
955OK, looks like a reasonable trial design. It would be nice to know how long it tuck-4/1/2004
954Maybe, finally, some forward motion coming? >>BOSTON--(BUSINESS WIRE)--Matuck-3/26/2004
953The below article is about some early stage research that looks pretty exciting.JMarcus-2/23/2004
952>>BOSTON--(BUSINESS WIRE)--Feb. 17, 2004-- Boston Life Sciences, Inc. (NAStuck-2/17/2004
951Incredible jump in short interest: Date: Short Int: Avg.Vol: Days to coverJorgen Jensen-12/28/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News